Countries
FY, 2021
Products
FY, 2021
Phase II Trials Products (Viral Diseases)
FY, 2021
Metrics | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|
Countries | 35 | 35 | 35 |
Products | 24 | 20 | 21 |
Phase II Trials Products (Viral Diseases) | 2 | 3 | 1 |
Phase I Trials Products (Viral Diseases) | 3 | ||
Phase III Trials Products (Inflammatory and Fibrotic Diseases) | 3 | 2 | 2 |
Phase II Trials Products (Inflammatory and Fibrotic Diseases) | 7 | ||
Phase I Trials Products (Inflammatory and Fibrotic Diseases) | 4 | ||
Phase III Trials Products (Oncology) | 1 | 3 | 4 |
Phase II Trials Products (Oncology) | 2 | 3 | 1 |
Phase I Trials Products (Oncology) | 7 | ||
Clinical Trials | 104 | ||
Phase III Trials Products | 27 | 8 | 9 |
Phase III Trial Products (Viral Diseases) | 3 | 3 |
Community
Employees
Environment
Governance
Source:CSRHub